Search

Author/Creator Collingwood, Therese

1. Phase I trials of the lysine-specific demethylase 1 inhibitor, GSK2879552, as mono- and combination-therapy in relapsed/refractory acute myeloid leukemia or high-risk myelodysplastic syndromes. Issue 2 (28th January 2022)

Authors:
Roboz, Gail J.; Yee, Karen; Verma, Amit; Borthakur, Gautam; de la Fuente Burguera, Adolfo; Sanz, Guillermo; Mohammad, Helai P.; Kruger, Ryan G.; Karpinich, Natalie O.; Ferron-Brady, Geraldine; Acusta, Andre; Del Buono, Heather; Collingwood, Therese; Ballas, Marc; Dhar, Arindam; Wei, Andrew H.
Journal:
Leukemia & lymphoma
Issue:
Volume 63:Issue 2(2022)
Page Start:
463
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗